# Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery

> **NCT02540265** · PHASE2 · COMPLETED · sponsor: **Baudax Bio** · enrollment: 59 (actual)

## Conditions studied

- Pain, Post-operative

## Interventions

- **DRUG:** N1539
- **DRUG:** Intravenous Placebo

## Key facts

- **NCT ID:** NCT02540265
- **Lead sponsor:** Baudax Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2017-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02540265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02540265, "Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02540265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*